Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature - PubMed (original) (raw)
Review
Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature
Kazandra Ruiz-Colón et al. Forensic Sci Int. 2014 Jul.
Abstract
Xylazine is not a controlled substance; it is marketed as a veterinary drug and used as a sedative, analgesic and muscle relaxant. In humans, it could cause central nervous system depression, respiratory depression, bradycardia, hypotension, and even death. There have been publications of 43 cases of xylazine intoxication in humans, in which 21 (49%) were non-fatal scenarios and 22 (51%) resulted in fatalities. Most of the non-fatal cases required medical intervention. Over recent years xylazine has emerged as an adulterant in recreational drugs, such as heroin or speedball (a cocaine and heroin mixture). From the 43 reported cases, 17 (40%) were associated with the use of xylazine as an adulterant of drugs of abuse. Its chronic use is reported to be associated with physical deterioration and skin ulceration. Literature shows some similar pharmacologic effects between xylazine and heroin in humans. These similar pharmacologic effects may create synergistic toxic effects in humans. Therefore, fatalities among drug users may increase due to the use of xylazine as an adulterant. Xylazine alone has proven harmful to humans and even more when it is combined with drugs of abuse. A comprehensive review of the literature of non-fatal and fatal xylazine intoxication cases including those in which the substance was used as adulterant is presented, in order to increase the awareness in the forensic community, law enforcement, and public health agencies.
Keywords: Adulterant; Cocaine; Heroin; Speedball; Xylazine.
Published by Elsevier Ireland Ltd.
Similar articles
- Xylazine: A Drug Adulterant of Clinical Concern.
Edinoff AN, Sall S, Upshaw WC, Spillers NJ, Vincik LY, De Witt AS, Murnane KS, Kaye AM, Kaye AD. Edinoff AN, et al. Curr Pain Headache Rep. 2024 May;28(5):417-426. doi: 10.1007/s11916-024-01211-z. Epub 2024 Mar 20. Curr Pain Headache Rep. 2024. PMID: 38507135 Free PMC article. Review. - Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication Deaths.
Nunez J, DeJoseph ME, Gill JR. Nunez J, et al. Am J Forensic Med Pathol. 2021 Mar 1;42(1):9-11. doi: 10.1097/PAF.0000000000000622. Am J Forensic Med Pathol. 2021. PMID: 33031124 - Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office.
Wong SC, Curtis JA, Wingert WE. Wong SC, et al. J Forensic Sci. 2008 Mar;53(2):495-8. doi: 10.1111/j.1556-4029.2007.00648.x. Epub 2008 Feb 14. J Forensic Sci. 2008. PMID: 18284526 - Xylazine (veterinary sedative) use in Puerto Rico.
Torruella RA. Torruella RA. Subst Abuse Treat Prev Policy. 2011 Apr 11;6:7. doi: 10.1186/1747-597X-6-7. Subst Abuse Treat Prev Policy. 2011. PMID: 21481268 Free PMC article. - Pharmacology and toxicology of xylazine: quid novum?
Malaca S, Pesaresi M, Kapoor A, Berretta P, Busardò FP, Pirani F. Malaca S, et al. Eur Rev Med Pharmacol Sci. 2023 Aug;27(15):7337-7345. doi: 10.26355/eurrev_202308_33305. Eur Rev Med Pharmacol Sci. 2023. PMID: 37606142 Review.
Cited by
- National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings.
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. Perrone J, et al. Ann Emerg Med. 2024 Jul;84(1):20-28. doi: 10.1016/j.annemergmed.2024.01.041. Epub 2024 Mar 16. Ann Emerg Med. 2024. PMID: 38493376 Free PMC article. Review. - Unsettling trend: The alarming rise of human abuse of veterinary drugs and its consequences.
Sharma A, Choudhary C, Vardhan G, Kumar V, Dhamija P, Kumar A. Sharma A, et al. J Family Med Prim Care. 2024 Aug;13(8):2823-2825. doi: 10.4103/jfmpc.jfmpc_165_24. Epub 2024 Jul 26. J Family Med Prim Care. 2024. PMID: 39228592 Free PMC article. - Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA.
Malayala SV, Papudesi BN, Bobb R, Wimbush A. Malayala SV, et al. Cureus. 2022 Aug 19;14(8):e28160. doi: 10.7759/cureus.28160. eCollection 2022 Aug. Cureus. 2022. PMID: 36148197 Free PMC article. - Xylazine and Overdoses: Trends, Concerns, and Recommendations.
Alexander RS, Canver BR, Sue KL, Morford KL. Alexander RS, et al. Am J Public Health. 2022 Aug;112(8):1212-1216. doi: 10.2105/AJPH.2022.306881. Am J Public Health. 2022. PMID: 35830662 Free PMC article. - Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?
Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Albertson TE, et al. J Med Toxicol. 2014 Dec;10(4):369-81. doi: 10.1007/s13181-014-0430-3. J Med Toxicol. 2014. PMID: 25238670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical